Home/Filings/4/0001757274-25-000004
4//SEC Filing

Lamba Sanjiv 4

Accession 0001757274-25-000004

CIK 0001707925other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 3:26 PM ET

Size

20.5 KB

Accession

0001757274-25-000004

Insider Transaction Report

Form 4
Period: 2025-12-08
Lamba Sanjiv
DirectorChief Executive Officer
Transactions
  • Purchase

    Ordinary Shares

    2025-12-08$396.68/sh+2,520$999,63490,794.191 total
Holdings
  • Restricted Stock Units

    Exercise: $0.00Ordinary Shares (6,364 underlying)
    6,364
  • Restricted Stock Units

    Ordinary Shares (6,405 underlying)
    6,405
  • Restricted Stock Units

    Ordinary Shares (7,015 underlying)
    7,015
  • Stock Options (right to buy)

    Exercise: $468.77Exp: 2035-03-07Ordinary Shares (44,696 underlying)
    44,696
  • Stock Options (right to buy)

    Exercise: $465.29Exp: 2034-03-07Ordinary Shares (41,530 underlying)
    41,530
  • Stock Options (right to buy)

    Exercise: $354.14Exp: 2033-03-07Ordinary Shares (46,365 underlying)
    46,365
  • Stock Options (right to buy)

    Exercise: $270.99Exp: 2032-03-07Ordinary Shares (54,920 underlying)
    54,920
  • Stock Options (right to buy)

    Exercise: $253.68Exp: 2031-03-08Ordinary Shares (40,995 underlying)
    40,995
  • Stock Options (right to buy)

    Exercise: $173.13Exp: 2030-03-09Ordinary Shares (37,565 underlying)
    37,565
  • Stock Options (right to buy)

    Exercise: $176.63Exp: 2029-03-20Ordinary Shares (15,470 underlying)
    15,470
  • Deferred Stock Units

    Exercise: $0.00Ordinary Shares (410.272 underlying)
    410.272
Footnotes (13)
  • [F1]The price reported is the weighted average purchase price. The purchase prices ranged from $396.39 to $397.00. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
  • [F10]This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
  • [F11]This option vests over three years in three consecutive equal annual installments beginning March 20, 2020.
  • [F12]Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
  • [F13]Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.
  • [F2]Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F3]Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F4]Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F5]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
  • [F6]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
  • [F7]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
  • [F8]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
  • [F9]This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

Issuer

LINDE PLC

CIK 0001707925

Entity typeother

Related Parties

1
  • filerCIK 0001757274

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 3:26 PM ET
Size
20.5 KB